Clinical Response of Tislelizumab Combined with Chemotherapy in Stage IV Small Cell Lung Cancer: A Retrospective Study

X. Yang, L. Liang, Y. Tang,Y. Song, G. Xu, X. Ke, C. Chen

Journal of Thoracic Oncology（2023）

引用 0|浏览23

暂无评分

摘要

Immunotherapy has revolutionized the treatment landscape of advanced cancer including stage IV small cell lung cancer (SCLC). But few data on stage IV SCLC patients to systemic therapy achieving a clinical downstaging have been reported. The purpose of this study was to evaluate the clinical response and safety of stage IV SCLC patients after treatment with tislelizumab combined with chemotherapy.

查看译文

关键词

Stage IV Small Cell Lung Cancer,Immunotherapy,Chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要